Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fina C Barouch

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Ophthalmology Clinics of North America|August 29, 2006
Potential future targets for treating ocular neovascularizationFina C Barouch, Joan W Miller
International Ophthalmology Clinics|June 24, 2004
Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degenerationFina C Barouch, Joan W Miller
International Ophthalmology Clinics|April 24, 2007
The role of inflammation and infection in age-related macular degenerationFina C Barouch, Joan W Miller
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2004
Isolated vitreoretinal amyloidosis in the absence of transthyretin mutationsFina C Barouch, Merrill D Benson, Shizuo Mukai
Retina (Philadelphia, Pa.)|November 25, 2010
Randomized trial of anesthetic methods for intravitreal injectionsGregory R Blaha, Elisha P Tilton, Fina C Barouch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 15, 2021
Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment CostsDavid J Ramsey, Samuel J Poulin, Lauren C LaMonica, et al.
Retina (Philadelphia, Pa.)|August 28, 2014
Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medicationsGregory R Blaha, Nneka O Brooks, Charles E Mackel, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Ophthalmology Clinics of North America|August 29, 2006
Potential future targets for treating ocular neovascularizationFina C Barouch, Joan W Miller
International Ophthalmology Clinics|June 24, 2004
Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degenerationFina C Barouch, Joan W Miller
International Ophthalmology Clinics|April 24, 2007
The role of inflammation and infection in age-related macular degenerationFina C Barouch, Joan W Miller
Archives of Ophthalmology (Chicago, Ill. : 1960)|January 14, 2004
Isolated vitreoretinal amyloidosis in the absence of transthyretin mutationsFina C Barouch, Merrill D Benson, Shizuo Mukai
Retina (Philadelphia, Pa.)|November 25, 2010
Randomized trial of anesthetic methods for intravitreal injectionsGregory R Blaha, Elisha P Tilton, Fina C Barouch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|January 15, 2021
Early Conversion to Aflibercept for Persistent Diabetic Macular Edema Results in Better Visual Outcomes and Lower Treatment CostsDavid J Ramsey, Samuel J Poulin, Lauren C LaMonica, et al.
Retina (Philadelphia, Pa.)|August 28, 2014
Changes in flare after intravitreal injection of three different anti-vascular endothelial growth factor medicationsGregory R Blaha, Nneka O Brooks, Charles E Mackel, et al.
Pageof 1